ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MIGUEL AYALA MD

Internal Medicine

17,360

$1.09M

896
647 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

SREENIVASULU CHERLO M.D.

Internal Medicine

17,297

$805K

617
434 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $67

NUSRAT SOLEJA M.D.

Internal Medicine

17,204

$838K

554
396 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

PRABHA MOHAN M.D.

Internal Medicine

17,193

$891K

550
396 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

43%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

KAHTAN KAISSI M.D.

Internal Medicine

17,191

$856K

875
810 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

RANDALL BARNES D.O.

Internal Medicine

17,178

$1.07M

516
476 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

GABRIEL GONZALEZ M.D.

Internal Medicine

17,162

$1.29M

562
495 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

BLANCA GRAY MD

Internal Medicine

17,159

$1.03M

610
447 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

SHEHETAJ ABDURRAHIM MD

Internal Medicine

17,146

$1.05M

675
516 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

CARL EARNEST M.D.

Internal Medicine

17,014

$704K

783
699 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$41
Average prescription price

Avg: $67

JOSE MARTINEZ MD

Internal Medicine

17,011

$937K

695
499 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

DARRELL PARSONS M.D.

Internal Medicine

16,991

$1.1M

640
574 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $67

YURI CABALLERO MD

Internal Medicine

16,943

$848K

792
636 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

MAXIMILIANO HERNANDEZ M.D.

Internal Medicine

16,923

$2.04M

879
728 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$120
Average prescription price

Avg: $67

ZAYD KAYLANI MD PA

Internal Medicine

16,845

$668K

515
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$40
Average prescription price

Avg: $67

RUSTON JENNINGS M.D.

Internal Medicine

16,841

$1.12M

728
677 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

SUTHEE THUMASATHIT MD

Internal Medicine

16,783

$836K

594
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

PAUL KIM MD

Internal Medicine

16,781

$849K

1048
933 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

GABRIELA HUNKO M.D.

Internal Medicine

16,753

$1.4M

1152
947 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $67

GARY BUTKA M.D.

Internal Medicine

16,733

$1.14M

649
504 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $67

MOGBOLAHAN KUYE MD

Internal Medicine

16,716

$891K

785
583 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

LESTER ONG M.D.

Internal Medicine

16,659

$957K

568
475 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

MILTON HABER M.D.

Internal Medicine

16,631

$816K

498
391 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

SANJAY REDDY M.D;M.P.H

Internal Medicine

16,609

$1.02M

675
506 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

VALARIE ALLMAN M.D.

Internal Medicine

16,569

$957K

736
593 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank